126 related articles for article (PubMed ID: 1863900)
1. Changes in the levels of house dust mite specific IgG4 during immunotherapy in asthmatic children.
Tsai LC; Tang RB; Hung MW; Chang ZN
Clin Exp Allergy; 1991 May; 21(3):367-72. PubMed ID: 1863900
[TBL] [Abstract][Full Text] [Related]
2. IgG4 antibodies in patients with house-dust-mite-sensitive bronchial asthma: relationship with antigen-specific immunotherapy.
Nakagawa T; Takaishi T; Sakamoto Y; Ito K; Miyamoto T; Skvaril F
Int Arch Allergy Appl Immunol; 1983; 71(2):122-5. PubMed ID: 6188704
[TBL] [Abstract][Full Text] [Related]
3. Analysis of house dust mite-specific IgE, IgG4, and IgG antibodies during immunotherapy in asthmatic children.
Lin KL; Wang SY; Hsieh KH
Ann Allergy; 1991 Jul; 67(1):63-9. PubMed ID: 1859043
[TBL] [Abstract][Full Text] [Related]
4. Specific IgE, IgG and IgG4 antibodies against house dust mite in patients with bronchial asthma.
Okazaki M; Kitani H; Mifune T; Mitsunobu F; Asaumi N; Tanizaki Y; Harada H; Takahashi K; Kimura I
Acta Med Okayama; 1991 Aug; 45(4):267-73. PubMed ID: 1962533
[TBL] [Abstract][Full Text] [Related]
5. Significance of specific IgG subclass antibodies to house dust mites in asthmatic children.
Tang RB; Tsai LC; Chao PL; Hung MW
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jun; 63(6):440-6. PubMed ID: 10925533
[TBL] [Abstract][Full Text] [Related]
6. Seasonal variation of IgG subclass antibodies to house dust mite in sera from mite-sensitive asthmatic patients.
Nahm DH; Park HS; Kim CW; Park JW; Hong CS
Ann Allergy Asthma Immunol; 1998 May; 80(5):411-5. PubMed ID: 9609612
[TBL] [Abstract][Full Text] [Related]
7. The change of allergen-specific IgG subclass antibodies during immunotherapy in mite-sensitive asthmatic children.
Wang JY; Lei HY; Hsieh KH
Asian Pac J Allergy Immunol; 1992 Jun; 10(1):11-8. PubMed ID: 1418178
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of household dust mite exposure and levels of specific IgE and IgG antibodies in asthmatic patients enrolled in a trial of immunotherapy.
Rose G; Arlian L; Bernstein D; Grant A; Lopez M; Metzger J; Wasserman S; Platts-Mills TA
J Allergy Clin Immunol; 1996 May; 97(5):1071-8. PubMed ID: 8626984
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of immune parameters (including specific IgG4) during immunotherapy.
Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA
Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244
[TBL] [Abstract][Full Text] [Related]
10. Correlation between serum IgE and specific IgE antibody titer to house dust mite in children with asthma.
Tsai LC; Tang RB; Hung MW; Chen HM; Hwang LA
J Asthma; 1988; 25(1):7-13. PubMed ID: 3182578
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of rapid injection immunotherapy by antigen specific IgE and IgG4 antibodies].
Satoh Y; Sugimoto K; Kuroki H; Fuzimoto N; Suzuki H
Arerugi; 1989 Mar; 38(3):246-53. PubMed ID: 2751431
[TBL] [Abstract][Full Text] [Related]
12. Modulation of mucosal/systemic antibody response after sublingual immunotherapy in mite-allergic children.
Queirós MG; Silva DA; Siman IL; Ynoue LH; Araújo NS; Pereira FL; Almeida KC; Miranda JS; Pena JD; Cunha-Junior JP; Taketomi EA
Pediatr Allergy Immunol; 2013 Dec; 24(8):752-61. PubMed ID: 24299565
[TBL] [Abstract][Full Text] [Related]
13. Natural immunity to dust mites in adults with chronic asthma. I. Mite-specific serum IgG and IgE.
Soliman MY; Rosenstreich DL
Am Rev Respir Dis; 1986 Nov; 134(5):962-8. PubMed ID: 3777694
[TBL] [Abstract][Full Text] [Related]
14. House dust mite-specific IgE, IgG1, and IgG4 antibodies in patients with perennial rhinitis.
Ohashi Y; Nakai Y; Kihara S; Nakagawa T; Miyamoto T
Ann Otol Rhinol Laryngol; 1987; 96(4):434-7. PubMed ID: 3619289
[TBL] [Abstract][Full Text] [Related]
15. IgG subclass antibodies in response to house dust mite immunotherapy.
Nakagawa T
N Engl Reg Allergy Proc; 1987; 8(6):423-8. PubMed ID: 3481430
[TBL] [Abstract][Full Text] [Related]
16. Changes of house dust mite-specific IgE, IgG and IgG subclass antibodies during immunotherapy in patients with perennial rhinitis.
Nakagawa T; Kozeki H; Katagiri J; Fujita Y; Yamashita N; Miyamoto T; Skvaril F
Int Arch Allergy Appl Immunol; 1987; 82(1):95-9. PubMed ID: 3804457
[TBL] [Abstract][Full Text] [Related]
17. Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy.
Bousquet J; Hejjaoui A; Clauzel AM; Guérin B; Dhivert H; Skassa-Brociek W; Michel FB
J Allergy Clin Immunol; 1988 Dec; 82(6):971-7. PubMed ID: 3204255
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of mite Dermatophagoides farinae allergen-specific IgG and IgG subclass distribution in patients on immunotherapy.
Einarsson R; Dreborg S; Hammarström L; Löfkvist T; Smith CI; Svensson G
Allergy; 1992 Apr; 47(2 Pt 1):76-82. PubMed ID: 1378700
[TBL] [Abstract][Full Text] [Related]
19. Immunologic changes during immunotherapy in asthmatic children: increased IL-13 and allergen-specific IgG4 antibody levels.
Lu FM; Chou CC; Chiang BL; Hsieh KH
Ann Allergy Asthma Immunol; 1998 May; 80(5):419-23. PubMed ID: 9609614
[TBL] [Abstract][Full Text] [Related]
20. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens.
Chen S; Zheng Y; Chen B; Zhong H; Liao F; Wang L; Hui SF; Lai X
Int Arch Allergy Immunol; 2019; 178(2):201-210. PubMed ID: 30544116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
